title: Autoimmune Hepatitis in the Liver Transplant Graft.
abstract: Recurrent autoimmune hepatitis (AIH) and de novo AIH are 2 important causes of late graft failure after liver transplantation (LT). Recurrent AIH occurs in patients who undergo LT for AIH. De novo AIH occurs in patients who are transplanted for etiologies other than AIH. Although typically treated with standard treatment for AIH, including corticosteroids and azathioprine, both recurrent and de novo AIH may progress to end-stage liver disease requiring retransplantation.
authors.affiliation: Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, 395 West 12th Avenue, Suite 100, Columbus, OH 43210, USA.
authors.forename: Eliza W
authors.initials: EW
authors.lastname: Beal
authors.affiliation: Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, 395 West 12th Avenue, Suite 100, Columbus, OH 43210, USA.
authors.forename: Sylvester M
authors.initials: SM
authors.lastname: Black
authors.affiliation: Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, 395 West 12th Avenue, Suite 200, Columbus, OH 43210, USA. Electronic address: Anthony.Michaels@osumc.edu.
authors.forename: Anthony
authors.initials: A
authors.lastname: Michaels
mesh_terms: D001323:Autoantibodies / Q000276:immunology*; D019693:Hepatitis, Autoimmune / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation; D012008:Recurrence; D012307:Risk Factors
chemical_list: D001323:Autoantibodies; D007166:Immunosuppressive Agents
keywords: Autoimmune hepatitis; De novo autoimmune hepatitis; Recurrent autoimmune hepatitis